Xenotransplantation and risk: regulating a developing biotechnology
Gespeichert in:
| 1. Verfasser: | |
|---|---|
| Format: | Elektronisch E-Book |
| Sprache: | English |
| Veröffentlicht: |
Cambridge, U.K.
Cambridge University Press
2012
|
| Schriftenreihe: | Cambridge law, medicine, and ethics
|
| Schlagworte: | |
| Online-Zugang: | TUM01 Volltext |
| Beschreibung: | "Some developing biotechnologies challenge accepted legal and ethical norms because of the risks they pose. Xenotransplantation (cross-species transplantation) may prolong life but may also harm the xeno-recipient and the public due to its potential to transmit infectious diseases. These trans-boundary diseases emphasise the global nature of advances in health care and highlight the difficulties of identifying, monitoring and regulating such risks and thereby protecting individual and public health. Xenotransplantation raises questions about how uncertainty and risk are understood and accepted, and exposes tensions between private benefit and public health. Where public health is at risk, a precautionary approach informed by the harm principle supports prioritising the latter, but the issues raised by genetically engineered solid organ xenotransplants have not, as yet, been sufficiently discussed. This must occur prior to their clinical introduction because of the necessary changes to accepted norms which are needed to appropriately safeguard individual and public health"-- Introducing the issues -- Dealing with risk -- Regulating experimental procedures and medical research -- Regulatory responses to developing biotechnologies -- Challenges to legal and ethical norms : first party consent and third parties at risk -- Surveillance and monitoring : balancing public health and individual freedom -- Summary and concluding thoughts : looking to the future Includes bibliographical references and index |
| Beschreibung: | 1 Online-Ressource (xiii, 291 p.) |
| ISBN: | 1139026925 1139223526 9780521195768 9781139026925 9781139223522 |
Internformat
MARC
| LEADER | 00000nmm a2200000zc 4500 | ||
|---|---|---|---|
| 001 | BV040473782 | ||
| 003 | DE-604 | ||
| 005 | 20140411 | ||
| 007 | cr|uuu---uuuuu | ||
| 008 | 121011s2012 |||| o||u| ||||||eng d | ||
| 020 | |a 1139026925 |c electronic bk. |9 1-139-02692-5 | ||
| 020 | |a 1139223526 |c electronic bk. |9 1-139-22352-6 | ||
| 020 | |a 9780521195768 |9 978-0-521-19576-8 | ||
| 020 | |a 9781139026925 |c electronic bk. |9 978-1-139-02692-5 | ||
| 020 | |a 9781139223522 |c electronic bk. |9 978-1-139-22352-2 | ||
| 035 | |a (OCoLC)874194556 | ||
| 035 | |a (DE-599)BVBBV040473782 | ||
| 040 | |a DE-604 |b ger |e aacr | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-91 | ||
| 100 | 1 | |a Fovargue, Sara |e Verfasser |4 aut | |
| 245 | 1 | 0 | |a Xenotransplantation and risk |b regulating a developing biotechnology |c Sara Fovargue |
| 264 | 1 | |a Cambridge, U.K. |b Cambridge University Press |c 2012 | |
| 300 | |a 1 Online-Ressource (xiii, 291 p.) | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b c |2 rdamedia | ||
| 338 | |b cr |2 rdacarrier | ||
| 490 | 0 | |a Cambridge law, medicine, and ethics | |
| 500 | |a "Some developing biotechnologies challenge accepted legal and ethical norms because of the risks they pose. Xenotransplantation (cross-species transplantation) may prolong life but may also harm the xeno-recipient and the public due to its potential to transmit infectious diseases. These trans-boundary diseases emphasise the global nature of advances in health care and highlight the difficulties of identifying, monitoring and regulating such risks and thereby protecting individual and public health. Xenotransplantation raises questions about how uncertainty and risk are understood and accepted, and exposes tensions between private benefit and public health. Where public health is at risk, a precautionary approach informed by the harm principle supports prioritising the latter, but the issues raised by genetically engineered solid organ xenotransplants have not, as yet, been sufficiently discussed. This must occur prior to their clinical introduction because of the necessary changes to accepted norms which are needed to appropriately safeguard individual and public health"-- | ||
| 500 | |a Introducing the issues -- Dealing with risk -- Regulating experimental procedures and medical research -- Regulatory responses to developing biotechnologies -- Challenges to legal and ethical norms : first party consent and third parties at risk -- Surveillance and monitoring : balancing public health and individual freedom -- Summary and concluding thoughts : looking to the future | ||
| 500 | |a Includes bibliographical references and index | ||
| 650 | 7 | |a LAW / Medical Law & Legislation |2 bisacsh | |
| 650 | 4 | |a Ethik | |
| 650 | 4 | |a Xenografts | |
| 650 | 4 | |a Transplantation immunology | |
| 650 | 4 | |a Xenografts / Moral and ethical aspects | |
| 650 | 4 | |a Transplantation of organs, tissues, etc | |
| 650 | 4 | |a LAW / Medical Law & Legislation / bisacsh | |
| 650 | 4 | |a Transplantation, Heterologous | |
| 650 | 4 | |a Transplantation, Heterologous / ethics | |
| 650 | 4 | |a Transplantation, Heterologous / legislation & jurisprudence | |
| 856 | 4 | 0 | |u http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=416671 |x Verlag |3 Volltext |
| 912 | |a ZDB-4-NLEBK | ||
| 999 | |a oai:aleph.bib-bvb.de:BVB01-025321071 | ||
| 966 | e | |u http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=416671 |l TUM01 |p ZDB-4-NLEBK |q TUM_PDA_EBSCO_MED_gekauft |x Verlag |3 Volltext | |
Datensatz im Suchindex
| _version_ | 1804149536871940096 |
|---|---|
| any_adam_object | |
| author | Fovargue, Sara |
| author_facet | Fovargue, Sara |
| author_role | aut |
| author_sort | Fovargue, Sara |
| author_variant | s f sf |
| building | Verbundindex |
| bvnumber | BV040473782 |
| collection | ZDB-4-NLEBK |
| ctrlnum | (OCoLC)874194556 (DE-599)BVBBV040473782 |
| format | Electronic eBook |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>03467nmm a2200505zc 4500</leader><controlfield tag="001">BV040473782</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">20140411 </controlfield><controlfield tag="007">cr|uuu---uuuuu</controlfield><controlfield tag="008">121011s2012 |||| o||u| ||||||eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">1139026925</subfield><subfield code="c">electronic bk.</subfield><subfield code="9">1-139-02692-5</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">1139223526</subfield><subfield code="c">electronic bk.</subfield><subfield code="9">1-139-22352-6</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9780521195768</subfield><subfield code="9">978-0-521-19576-8</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9781139026925</subfield><subfield code="c">electronic bk.</subfield><subfield code="9">978-1-139-02692-5</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9781139223522</subfield><subfield code="c">electronic bk.</subfield><subfield code="9">978-1-139-22352-2</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)874194556</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV040473782</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">aacr</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-91</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Fovargue, Sara</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Xenotransplantation and risk</subfield><subfield code="b">regulating a developing biotechnology</subfield><subfield code="c">Sara Fovargue</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Cambridge, U.K.</subfield><subfield code="b">Cambridge University Press</subfield><subfield code="c">2012</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 Online-Ressource (xiii, 291 p.)</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="0" ind2=" "><subfield code="a">Cambridge law, medicine, and ethics</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">"Some developing biotechnologies challenge accepted legal and ethical norms because of the risks they pose. Xenotransplantation (cross-species transplantation) may prolong life but may also harm the xeno-recipient and the public due to its potential to transmit infectious diseases. These trans-boundary diseases emphasise the global nature of advances in health care and highlight the difficulties of identifying, monitoring and regulating such risks and thereby protecting individual and public health. Xenotransplantation raises questions about how uncertainty and risk are understood and accepted, and exposes tensions between private benefit and public health. Where public health is at risk, a precautionary approach informed by the harm principle supports prioritising the latter, but the issues raised by genetically engineered solid organ xenotransplants have not, as yet, been sufficiently discussed. This must occur prior to their clinical introduction because of the necessary changes to accepted norms which are needed to appropriately safeguard individual and public health"--</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Introducing the issues -- Dealing with risk -- Regulating experimental procedures and medical research -- Regulatory responses to developing biotechnologies -- Challenges to legal and ethical norms : first party consent and third parties at risk -- Surveillance and monitoring : balancing public health and individual freedom -- Summary and concluding thoughts : looking to the future</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Includes bibliographical references and index</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">LAW / Medical Law & Legislation</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Ethik</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Xenografts</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Transplantation immunology</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Xenografts / Moral and ethical aspects</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Transplantation of organs, tissues, etc</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">LAW / Medical Law & Legislation / bisacsh</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Transplantation, Heterologous</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Transplantation, Heterologous / ethics</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Transplantation, Heterologous / legislation & jurisprudence</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=416671</subfield><subfield code="x">Verlag</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-4-NLEBK</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-025321071</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=416671</subfield><subfield code="l">TUM01</subfield><subfield code="p">ZDB-4-NLEBK</subfield><subfield code="q">TUM_PDA_EBSCO_MED_gekauft</subfield><subfield code="x">Verlag</subfield><subfield code="3">Volltext</subfield></datafield></record></collection> |
| id | DE-604.BV040473782 |
| illustrated | Not Illustrated |
| indexdate | 2024-07-10T00:24:36Z |
| institution | BVB |
| isbn | 1139026925 1139223526 9780521195768 9781139026925 9781139223522 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-025321071 |
| oclc_num | 874194556 |
| open_access_boolean | |
| owner | DE-91 DE-BY-TUM |
| owner_facet | DE-91 DE-BY-TUM |
| physical | 1 Online-Ressource (xiii, 291 p.) |
| psigel | ZDB-4-NLEBK ZDB-4-NLEBK TUM_PDA_EBSCO_MED_gekauft |
| publishDate | 2012 |
| publishDateSearch | 2012 |
| publishDateSort | 2012 |
| publisher | Cambridge University Press |
| record_format | marc |
| series2 | Cambridge law, medicine, and ethics |
| spelling | Fovargue, Sara Verfasser aut Xenotransplantation and risk regulating a developing biotechnology Sara Fovargue Cambridge, U.K. Cambridge University Press 2012 1 Online-Ressource (xiii, 291 p.) txt rdacontent c rdamedia cr rdacarrier Cambridge law, medicine, and ethics "Some developing biotechnologies challenge accepted legal and ethical norms because of the risks they pose. Xenotransplantation (cross-species transplantation) may prolong life but may also harm the xeno-recipient and the public due to its potential to transmit infectious diseases. These trans-boundary diseases emphasise the global nature of advances in health care and highlight the difficulties of identifying, monitoring and regulating such risks and thereby protecting individual and public health. Xenotransplantation raises questions about how uncertainty and risk are understood and accepted, and exposes tensions between private benefit and public health. Where public health is at risk, a precautionary approach informed by the harm principle supports prioritising the latter, but the issues raised by genetically engineered solid organ xenotransplants have not, as yet, been sufficiently discussed. This must occur prior to their clinical introduction because of the necessary changes to accepted norms which are needed to appropriately safeguard individual and public health"-- Introducing the issues -- Dealing with risk -- Regulating experimental procedures and medical research -- Regulatory responses to developing biotechnologies -- Challenges to legal and ethical norms : first party consent and third parties at risk -- Surveillance and monitoring : balancing public health and individual freedom -- Summary and concluding thoughts : looking to the future Includes bibliographical references and index LAW / Medical Law & Legislation bisacsh Ethik Xenografts Transplantation immunology Xenografts / Moral and ethical aspects Transplantation of organs, tissues, etc LAW / Medical Law & Legislation / bisacsh Transplantation, Heterologous Transplantation, Heterologous / ethics Transplantation, Heterologous / legislation & jurisprudence http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=416671 Verlag Volltext |
| spellingShingle | Fovargue, Sara Xenotransplantation and risk regulating a developing biotechnology LAW / Medical Law & Legislation bisacsh Ethik Xenografts Transplantation immunology Xenografts / Moral and ethical aspects Transplantation of organs, tissues, etc LAW / Medical Law & Legislation / bisacsh Transplantation, Heterologous Transplantation, Heterologous / ethics Transplantation, Heterologous / legislation & jurisprudence |
| title | Xenotransplantation and risk regulating a developing biotechnology |
| title_auth | Xenotransplantation and risk regulating a developing biotechnology |
| title_exact_search | Xenotransplantation and risk regulating a developing biotechnology |
| title_full | Xenotransplantation and risk regulating a developing biotechnology Sara Fovargue |
| title_fullStr | Xenotransplantation and risk regulating a developing biotechnology Sara Fovargue |
| title_full_unstemmed | Xenotransplantation and risk regulating a developing biotechnology Sara Fovargue |
| title_short | Xenotransplantation and risk |
| title_sort | xenotransplantation and risk regulating a developing biotechnology |
| title_sub | regulating a developing biotechnology |
| topic | LAW / Medical Law & Legislation bisacsh Ethik Xenografts Transplantation immunology Xenografts / Moral and ethical aspects Transplantation of organs, tissues, etc LAW / Medical Law & Legislation / bisacsh Transplantation, Heterologous Transplantation, Heterologous / ethics Transplantation, Heterologous / legislation & jurisprudence |
| topic_facet | LAW / Medical Law & Legislation Ethik Xenografts Transplantation immunology Xenografts / Moral and ethical aspects Transplantation of organs, tissues, etc LAW / Medical Law & Legislation / bisacsh Transplantation, Heterologous Transplantation, Heterologous / ethics Transplantation, Heterologous / legislation & jurisprudence |
| url | http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=416671 |
| work_keys_str_mv | AT fovarguesara xenotransplantationandriskregulatingadevelopingbiotechnology |